Detection of CTX-M-Type β-Lactamase Genes in Fecal Escherichia coli Isolates from Healthy Children in Bolivia and Peru
Open Access
- 1 December 2004
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 48 (12) , 4556-4561
- https://doi.org/10.1128/aac.48.12.4556-4561.2004
Abstract
A survey was carried out from August to November 2002 to evaluate the antimicrobial susceptibilities of fecal Escherichia coli isolates from 3,208 healthy children from four different urban areas of Latin America, two in Bolivia (Camiri and Villa Montes) and two in Peru (Yurimaguas and Moyobamba). Ceftriaxone-resistant E. coli isolates were detected in four children, one from each of the areas sampled. The isolates exhibited a multidrug-resistant phenotype, including resistance to oxyimino-cephalosporins and aztreonam, and the MICs of ceftazidime for the isolates were lower than those of cefotaxime. By PCR and sequencing, the bla CTX-M-2 determinant was detected in three isolates and the bla CTX-M-15 determinant was detected in one isolate (from Peru). The CTX-M-2-producing isolates belonged to three different phylogenetic groups (groups A, B2, and D), while the CTX-M-15-producing isolate belonged to phylogenetic group D. The bla CTX-M-2 determinants were transferable to E. coli by conjugation, while conjugative transfer of the bla CTX-M-15 determinant was not detectable. Plasmids harboring the bla CTX-M-2 determinant exhibited similar restriction profiles, and in all of them the gene was located on a 2.2-kb PstI fragment, suggesting a genetic environment similar to that present in In35 and InS21. The findings of the present study confirm the widespread distribution of CTX-M-type β-lactamases and underscore the role that commensal E. coli isolates could play as a potential reservoir of these clinically relevant resistance determinants. This is the first report of CTX-M-type enzymes in Bolivia and Peru and also the first report of the detection of CTX-M-15 in Latin America.Keywords
This publication has 35 references indexed in Scilit:
- High Prevalence of Acquired Antimicrobial Resistance Unrelated to Heavy Antimicrobial ConsumptionThe Journal of Infectious Diseases, 2004
- Growing Group of Extended-Spectrum β-Lactamases: the CTX-M EnzymesAntimicrobial Agents and Chemotherapy, 2004
- Extended-Spectrum β-Lactamases in Klebsiella pneumoniae Bloodstream Isolates from Seven Countries: Dominance and Widespread Prevalence of SHV- and CTX-M-Type β-LactamasesAntimicrobial Agents and Chemotherapy, 2003
- Confirmation of extended-spectrum β-lactamase-producing Serratia marcescens: preliminary report from TaiwanDiagnostic Microbiology and Infectious Disease, 2003
- Extended-spectrum β-lactamase types in Klebsiella pneumoniae and Escherichia coli in two Greek hospitalsInternational Journal of Antimicrobial Agents, 2003
- CTX-M-3 Extended-spectrum ß-lactamase in a Shigella sonnei Clinical Isolate: First Report from TurkeyScandinavian Journal of Infectious Diseases, 2003
- Early Dissemination of CTX-M-Derived Enzymes in South AmericaAntimicrobial Agents and Chemotherapy, 2002
- A between-Species Comparison of Antimicrobial Resistance in Enterobacteria in Fecal FloraAntimicrobial Agents and Chemotherapy, 2000
- Close amino acid sequence relationship between the new plasmid-mediated extended-spectrum β-lactamase MEN-1 and chromosomally encoded enzymes of Klebsiella oxytocaBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1992
- A new plasmidic cefotaximase from patients infected withSalmonella typhimuriumInfection, 1992